The Interventional Cardiology Devices market is valued at approximately $12.2 billion in 2020 and is expected to generate revenues of $18.1 billion in 2026, with a CAGR of 6.8% over the forecast period (2021-2027). Key growth drivers include increased adoption of minimally invasive surgery, increased worldwide prevalence of cardiovascular disease, and technological advances introduced in […]
